Physicians Realty Trust (NYSE:DOC)‘s stock had its “buy” rating restated by equities researchers at Stifel Nicolaus in a research report issued to clients and investors on Wednesday, October 4th. They currently have a $22.00 price objective on the real estate investment trust’s stock. Stifel Nicolaus’ price target would suggest a potential upside of 22.09% from the company’s current price.
A number of other analysts also recently issued reports on the stock. Cantor Fitzgerald reaffirmed a “buy” rating and set a $21.00 price target on shares of Physicians Realty Trust in a report on Tuesday, September 26th. Capital One Financial Corporation assumed coverage on shares of Physicians Realty Trust in a report on Monday, September 25th. They set an “equal weight” rating and a $19.50 price target on the stock. Jefferies Group LLC reaffirmed a “hold” rating and set a $19.00 price target (up previously from $18.00) on shares of Physicians Realty Trust in a report on Friday, September 22nd. Royal Bank Of Canada restated a “buy” rating and set a $21.00 target price on shares of Physicians Realty Trust in a research note on Wednesday, September 13th. Finally, KeyCorp reiterated a “hold” rating on shares of Physicians Realty Trust in a research report on Tuesday, September 12th. Five investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $20.54.
Physicians Realty Trust (DOC) opened at 18.02 on Wednesday. The company’s 50 day moving average is $18.20 and its 200-day moving average is $19.26. Physicians Realty Trust has a 52-week low of $17.12 and a 52-week high of $21.85. The company has a market capitalization of $2.84 billion, a price-to-earnings ratio of 77.01 and a beta of 0.53.
Physicians Realty Trust (NYSE:DOC) last announced its quarterly earnings data on Thursday, August 3rd. The real estate investment trust reported $0.24 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.23 by $0.01. The company had revenue of $76.60 million for the quarter, compared to the consensus estimate of $80.48 million. Physicians Realty Trust had a net margin of 11.51% and a return on equity of 1.75%. Physicians Realty Trust’s revenue for the quarter was up 43.9% on a year-over-year basis. During the same period in the prior year, the firm posted $0.22 EPS. Equities analysts anticipate that Physicians Realty Trust will post $0.26 EPS for the current fiscal year.
COPYRIGHT VIOLATION WARNING: “Physicians Realty Trust (DOC) Earns “Buy” Rating from Stifel Nicolaus” was first posted by BBNS and is the property of of BBNS. If you are accessing this story on another publication, it was illegally copied and reposted in violation of US and international trademark & copyright law. The legal version of this story can be read at https://baseballnewssource.com/markets/physicians-realty-trust-doc-stock-rating-reaffirmed-by-stifel-nicolaus/1697470.html.
A number of institutional investors have recently added to or reduced their stakes in DOC. Bank of New York Mellon Corp boosted its position in Physicians Realty Trust by 4.1% in the 1st quarter. Bank of New York Mellon Corp now owns 1,409,893 shares of the real estate investment trust’s stock worth $28,014,000 after purchasing an additional 55,472 shares in the last quarter. UBS Asset Management Americas Inc. raised its stake in Physicians Realty Trust by 33.7% in the 1st quarter. UBS Asset Management Americas Inc. now owns 277,629 shares of the real estate investment trust’s stock valued at $5,516,000 after purchasing an additional 69,901 shares during the last quarter. Karp Capital Management Corp acquired a new position in Physicians Realty Trust in the 1st quarter valued at $439,000. Ameritas Investment Partners Inc. raised its stake in Physicians Realty Trust by 11.3% in the 1st quarter. Ameritas Investment Partners Inc. now owns 12,989 shares of the real estate investment trust’s stock valued at $258,000 after purchasing an additional 1,315 shares during the last quarter. Finally, Envestnet Asset Management Inc. raised its stake in Physicians Realty Trust by 31.0% in the 1st quarter. Envestnet Asset Management Inc. now owns 52,793 shares of the real estate investment trust’s stock valued at $1,050,000 after purchasing an additional 12,506 shares during the last quarter. Institutional investors and hedge funds own 94.20% of the company’s stock.
Physicians Realty Trust Company Profile
Physicians Realty Trust (the Trust) is a real estate investment trust. Physicians Realty L.P. is the operating partnership of the Trust. The Trust and its operating partnership are engaged in acquiring, developing, owning and managing healthcare properties that are leased to physicians, hospitals and healthcare delivery systems.
Receive News & Ratings for Physicians Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physicians Realty Trust and related companies with our FREE daily email newsletter.